🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔴 Integrated role of CMR & genetics in predicting LV reverse remodelling in dilated & non-dilated cardiomyopathy European Society of Cardiology Journals #Cardiology #Cardioed #Genetics #WhyCmr #FOAMed

🆕 Cómo realizar la ecografía para la evaluación hemodinámica no invasiva en la unidad de cuidados intensivos. 📕 Journal of Cardiovascular Echography 🔓 Resumen del artículo en cardioteca.com/imagen/6576-co…

#NoDejesQueSeApague💡 La insuficiencia cardiaca representa el 25% de los ingresos hospitalarios por cardiopatías. omny.fm/shows/cardiopo… 🎙️En este #CardioPODCAST, Mercedes Rivas-Lasarte (Mercedes Rivas-Lasarte), Julia Seller (Julia Seller), Rafael Vidal (rafavidalperez) y Mercedes

#Obesity in👥 with #HeartFailure: a common challenge & a therapeutic target in #HFpEF. New #ESC_HFA Scientific 📝‼️ #PositionPaper #HF European Society of Cardiology #EHJHF

Finalizó nuestro XLII Congreso de las Enfermedades Cardiovasculares de la SVCardio #svc25 Muchas gracias a todos los ponentes, patrocinadores, y por supuesto a todos los asistentes ❗️ Nos vemos en #svc26❗️

🔴 Tirzepatide as Compared with Semaglutide for the Treatment of Obesity A head-to-head trial finally answers: is tirzepatide more effective than semaglutide for obesity in non-diabetics? We@NEJM: the SURMOUNT-5 trial. #Obesity #CardioTwitter #GLP1 #Tirzepatide #Semaglutide

#Heartfailure2025 is coming 📍Belgrade 🇷🇸 📅 17-20 May We are pleased to present 4 abstracts from our latest sub-analysis of the #CLOROTIC trial and #ALCALOTIC study by @ICyFA-SEMI Thanks again to all the investigators, collaborators, and presenters #Teamwork

📣We are proud to present the results of the #HERMeS trial recently published in The Lancet Digital Health ‼️ Evaluation of mobile health technology combining telemonitoring and te... sciencedirect.com/science/articl… Hospital Universitari Bellvitge | HUB IDIBELL CIBERCV Novartis Josep Comin Colet @ICyFA-SEMI

link.springer.com/article/10.100…

🔴Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial #HeartFailure2025 💡 The FINEARTS-HF trial shows that finerenone significantly ⬇️NT-proBNP and clinical events in patients with

Fantastic six decongestive rules💦 by Wilfried Mullens 1️⃣Door to diuretic time 2️⃣Appropriate dosing via IV bolus + combo 3️⃣Early evaluation of the diuretic effect 4️⃣Natriuresis guided approach 5️⃣Only stop when 'dry' while optimizing GDMT 6️⃣Monitor K/eGFR, diuresis, hemodynamics

#GDMT has now arrived for #HFpEF #SGLT2i (class I) and #nsMRA (class IIa) recommendations in initial global guidelines jstage.jst.go.jp/article/circj/… #HeartFailure2025

Simultaneous Publication in Journal of Cardiac Failure with #HeartFailure2025 #GOALSHF multinational implementation program Steve Greene Javed Butler Single-arm trial suggesting potential benefits of remote home based monitoring in #GDMT optimization onlinejcf.com/article/S1071-…

🔥#HeartFailure2025 #LBCT #DapaTAVI Quality of Life #SGLT2i dapa in severe AS undergoing TAVI Main paper NEJM ↓ deaths & worsening HF: nejm.org/doi/full/10.10… New LBCT Clara Bonanad curiously no incremental gains in QOL Great reporting by Todd Neale: tctmd.com/news/no-additi…

Con la resaca del #HeartFailure2025 no podía dejar de felicitar a J. Alberto Torres Zamudio y equipo. Un residente 🇪🇸 presentando un late breaking trial❗️Enhorabuena‼️💯 JóvenesSEC Asociación Insuficiencia Cardiaca Soc Esp Cardiología

.@juliasellerm: “El FRESH-UP cuestiona la restricción hídrica sistemática en pacientes con IC ambulatoria en fase estable y nos sugiere que un enfoque más liberal puede mejorar la calidad de vida sin un aumento de eventos adversos". #BlogSEC JóvenesSEC ow.ly/N7CB50W1mw8